Lærke Smidt Gasbjerg
  • Source: Scopus
20122024

Research activity per year

Personal profile

Short presentation

Research field: translational area between molecular pharmacology, clinical physiology and modern imaging techniques focusing on the endocrine system, cardiovascular system, and metabolism.

Expertise: peptide gut hormones related to nutrient metabolism involving ligand-receptor interactions, physiological actions, pathophysiological implications, and therapeutic potential. 

Key words: Peptide hormones, incretin effect, hormone physiology, pharmacology, GIP, GLP-1, GLP-2

CV

2023-present: Assistant Professor, Gasbjerg Group, Department of Biomedical Sciences

2020-23: BRIDGE Translational Excellence Programme Fellowship, University of Copenhagen (UCPH). Project: The role of the intestinal hormones GIP and GLP-2 in postprandial splanchnic blood flow distribution and metabolism in humans

2019-20: Residency (klinisk basisudannelse/KBU): Internal medicine, Hvidovre Hospital; General Practice, Vanløse

2019: PhD degree, UCPH.

2015-19: PhD title: Glucose-dependent insulinotropic polypeptide – the main incretin hormone in man. Supervisors: Profs. Filip K Knop, Jens J Holst, Tina Vilsbøll, Mette M Rosenkilde, Ass. Prof. Mikkel Christensen. Affiliations: Center for Clinical Metabolic Research, Gentofte Hospital; Steno Diabetes Center Copenhagen; Dep. Biomedical Sciences, UCPH

2015: Medical Doctor

2012: Master thesis: Glucose-dependent insulinotropic polypeptide receptor antagonists. Supervisor: Prof. Mette M Rosenkilde, Dep. Neuroscience and Pharmacology, UCPH

2008-2015: Medical school, UCPH

 

Possible conflicts of interest

Co-founder of Antag Therapeutics, CVR 38402056

Education/Academic qualification

Medicine

1 Feb 20089 Jan 2015

Award Date: 9 Jan 2015

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or